Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.

Identifieur interne : 000A21 ( PubMed/Corpus ); précédent : 000A20; suivant : 000A22

Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.

Auteurs : M. Mileva ; L. Tancheva ; R. Bakalova ; A. Galabov ; V. Savov ; S. Ribarov

Source :

RBID : pubmed:10713467

English descriptors

Abstract

Influenza virus infection was associated with development of oxidative stress in liver of mice, viz. increase in amount of lipid peroxidation products, decrease in cytochrome P-450 and NADP. H-cytochrome c-reductase activity, and inhibition of liver monooxygenases (aniline hydroxylase, ethylmorphine-N-demethylase, amidopyrine-N-demethylase and analgin-N-demethylase). These effects were most pronounced on the 7th day after virus inoculation as compared to the 5th one. Supplementation of mice with vitamin E before virus inoculation leads to liver protection against oxidative stress and toxicosis. A marked decrease of lipid peroxidation products and an increase of cytochrome P-450 and activities of monooxygenases was established. The stabilizing effect of vitamin E was dose-dependent and was most pronounced on the 5th day after virus inoculation as compared to the 7th one.

DOI: 10.1016/s0378-4274(99)00265-9
PubMed: 10713467

Links to Exploration step

pubmed:10713467

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.</title>
<author>
<name sortKey="Mileva, M" sort="Mileva, M" uniqKey="Mileva M" first="M" last="Mileva">M. Mileva</name>
<affiliation>
<nlm:affiliation>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia, Bulgaria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tancheva, L" sort="Tancheva, L" uniqKey="Tancheva L" first="L" last="Tancheva">L. Tancheva</name>
</author>
<author>
<name sortKey="Bakalova, R" sort="Bakalova, R" uniqKey="Bakalova R" first="R" last="Bakalova">R. Bakalova</name>
</author>
<author>
<name sortKey="Galabov, A" sort="Galabov, A" uniqKey="Galabov A" first="A" last="Galabov">A. Galabov</name>
</author>
<author>
<name sortKey="Savov, V" sort="Savov, V" uniqKey="Savov V" first="V" last="Savov">V. Savov</name>
</author>
<author>
<name sortKey="Ribarov, S" sort="Ribarov, S" uniqKey="Ribarov S" first="S" last="Ribarov">S. Ribarov</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10713467</idno>
<idno type="pmid">10713467</idno>
<idno type="doi">10.1016/s0378-4274(99)00265-9</idno>
<idno type="wicri:Area/PubMed/Corpus">000A21</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A21</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.</title>
<author>
<name sortKey="Mileva, M" sort="Mileva, M" uniqKey="Mileva M" first="M" last="Mileva">M. Mileva</name>
<affiliation>
<nlm:affiliation>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia, Bulgaria.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tancheva, L" sort="Tancheva, L" uniqKey="Tancheva L" first="L" last="Tancheva">L. Tancheva</name>
</author>
<author>
<name sortKey="Bakalova, R" sort="Bakalova, R" uniqKey="Bakalova R" first="R" last="Bakalova">R. Bakalova</name>
</author>
<author>
<name sortKey="Galabov, A" sort="Galabov, A" uniqKey="Galabov A" first="A" last="Galabov">A. Galabov</name>
</author>
<author>
<name sortKey="Savov, V" sort="Savov, V" uniqKey="Savov V" first="V" last="Savov">V. Savov</name>
</author>
<author>
<name sortKey="Ribarov, S" sort="Ribarov, S" uniqKey="Ribarov S" first="S" last="Ribarov">S. Ribarov</name>
</author>
</analytic>
<series>
<title level="j">Toxicology letters</title>
<idno type="ISSN">0378-4274</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aminopyrine N-Demethylase (antagonists & inhibitors)</term>
<term>Aminopyrine N-Demethylase (metabolism)</term>
<term>Aniline Hydroxylase (antagonists & inhibitors)</term>
<term>Aniline Hydroxylase (metabolism)</term>
<term>Animals</term>
<term>Cytochrome P-450 Enzyme Inhibitors</term>
<term>Cytochrome P-450 Enzyme System (metabolism)</term>
<term>Dipyrone (metabolism)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Ethylmorphine-N-Demethylase (antagonists & inhibitors)</term>
<term>Ethylmorphine-N-Demethylase (metabolism)</term>
<term>Influenza A virus (metabolism)</term>
<term>Lipid Peroxidation (drug effects)</term>
<term>Liver (drug effects)</term>
<term>Liver (enzymology)</term>
<term>Liver (virology)</term>
<term>Male</term>
<term>Mice</term>
<term>NADPH-Ferrihemoprotein Reductase (metabolism)</term>
<term>Orthomyxoviridae Infections (drug therapy)</term>
<term>Orthomyxoviridae Infections (enzymology)</term>
<term>Oxidative Stress (drug effects)</term>
<term>Thiobarbituric Acid Reactive Substances (metabolism)</term>
<term>Vitamin E (pharmacology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Aminopyrine N-Demethylase</term>
<term>Aniline Hydroxylase</term>
<term>Ethylmorphine-N-Demethylase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Aminopyrine N-Demethylase</term>
<term>Aniline Hydroxylase</term>
<term>Cytochrome P-450 Enzyme System</term>
<term>Dipyrone</term>
<term>Ethylmorphine-N-Demethylase</term>
<term>NADPH-Ferrihemoprotein Reductase</term>
<term>Thiobarbituric Acid Reactive Substances</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Lipid Peroxidation</term>
<term>Liver</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Liver</term>
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Vitamin E</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Liver</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cytochrome P-450 Enzyme Inhibitors</term>
<term>Dose-Response Relationship, Drug</term>
<term>Male</term>
<term>Mice</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Influenza virus infection was associated with development of oxidative stress in liver of mice, viz. increase in amount of lipid peroxidation products, decrease in cytochrome P-450 and NADP. H-cytochrome c-reductase activity, and inhibition of liver monooxygenases (aniline hydroxylase, ethylmorphine-N-demethylase, amidopyrine-N-demethylase and analgin-N-demethylase). These effects were most pronounced on the 7th day after virus inoculation as compared to the 5th one. Supplementation of mice with vitamin E before virus inoculation leads to liver protection against oxidative stress and toxicosis. A marked decrease of lipid peroxidation products and an increase of cytochrome P-450 and activities of monooxygenases was established. The stabilizing effect of vitamin E was dose-dependent and was most pronounced on the 5th day after virus inoculation as compared to the 7th one.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">10713467</PMID>
<DateCompleted>
<Year>2000</Year>
<Month>05</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>08</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0378-4274</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>114</Volume>
<Issue>1-3</Issue>
<PubDate>
<Year>2000</Year>
<Month>Apr</Month>
<Day>03</Day>
</PubDate>
</JournalIssue>
<Title>Toxicology letters</Title>
<ISOAbbreviation>Toxicol. Lett.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.</ArticleTitle>
<Pagination>
<MedlinePgn>39-45</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Influenza virus infection was associated with development of oxidative stress in liver of mice, viz. increase in amount of lipid peroxidation products, decrease in cytochrome P-450 and NADP. H-cytochrome c-reductase activity, and inhibition of liver monooxygenases (aniline hydroxylase, ethylmorphine-N-demethylase, amidopyrine-N-demethylase and analgin-N-demethylase). These effects were most pronounced on the 7th day after virus inoculation as compared to the 5th one. Supplementation of mice with vitamin E before virus inoculation leads to liver protection against oxidative stress and toxicosis. A marked decrease of lipid peroxidation products and an increase of cytochrome P-450 and activities of monooxygenases was established. The stabilizing effect of vitamin E was dose-dependent and was most pronounced on the 5th day after virus inoculation as compared to the 7th one.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mileva</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Physics and Biophysics, Medical University, 2 Zdrave Str., Sofia, Bulgaria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tancheva</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bakalova</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Galabov</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Savov</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ribarov</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Toxicol Lett</MedlineTA>
<NlmUniqueID>7709027</NlmUniqueID>
<ISSNLinking>0378-4274</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D065607">Cytochrome P-450 Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017392">Thiobarbituric Acid Reactive Substances</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1406-18-4</RegistryNumber>
<NameOfSubstance UI="D014810">Vitamin E</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6429L0L52Y</RegistryNumber>
<NameOfSubstance UI="D004177">Dipyrone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9035-51-2</RegistryNumber>
<NameOfSubstance UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.-</RegistryNumber>
<NameOfSubstance UI="D000815">Aniline Hydroxylase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.5.3.-</RegistryNumber>
<NameOfSubstance UI="D000633">Aminopyrine N-Demethylase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.5.3.-</RegistryNumber>
<NameOfSubstance UI="D005037">Ethylmorphine-N-Demethylase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.5.3.-</RegistryNumber>
<NameOfSubstance UI="C019666">amidopyrine N-demethylase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.6.2.4</RegistryNumber>
<NameOfSubstance UI="D009251">NADPH-Ferrihemoprotein Reductase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000633" MajorTopicYN="N">Aminopyrine N-Demethylase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000815" MajorTopicYN="N">Aniline Hydroxylase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065607" MajorTopicYN="N">Cytochrome P-450 Enzyme Inhibitors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004177" MajorTopicYN="N">Dipyrone</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005037" MajorTopicYN="N">Ethylmorphine-N-Demethylase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009251" MajorTopicYN="N">NADPH-Ferrihemoprotein Reductase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017392" MajorTopicYN="N">Thiobarbituric Acid Reactive Substances</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014810" MajorTopicYN="N">Vitamin E</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2000</Year>
<Month>3</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2000</Year>
<Month>5</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2000</Year>
<Month>3</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">10713467</ArticleId>
<ArticleId IdType="pii">S0378427499002659</ArticleId>
<ArticleId IdType="doi">10.1016/s0378-4274(99)00265-9</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A21 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000A21 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:10713467
   |texte=   Effect of vitamin E on lipid peroxidation and liver monooxigenase activity in experimental influenza virus infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:10713467" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021